Cancers | Selected Papers on Breast Cancer Published in 2024

We are pleased to share a selection of papers from the 2024 collection on the topic “Advances and Challenges in the Precision Management of Breast Cancer”, published in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.

1. “Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions”
by Rohan Kalyan Rej, Joyeeta Roy and Srinivasa Rao Allu
Cancers 2024, 16(3), 552; https://doi.org/10.3390/cancers16030552
Available online: https://www.mdpi.com/2072-6694/16/3/552

2. “Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond”
by Virginia Valentini, Agostino Bucalo, Giulia Conti, Ludovica Celli, Virginia Porzio, Carlo Capalbo, Valentina Silvestri and Laura Ottini
Cancers 2024, 16(3), 579; https://doi.org/10.3390/cancers16030579
Available online: https://www.mdpi.com/2072-6694/16/3/579

3. “The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant Chemotherapy”
by Corrado Tinterri, Bethania Fernandes, Alberto Zambelli, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Shadya Sara Darwish, Flavia Jacobs, Camilla De Carlo, Martina Iuzzolino et al.
Cancers 2024, 16(2), 376; https://doi.org/10.3390/cancers16020376
Available online: https://www.mdpi.com/2072-6694/16/2/376

4. “Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer”
by Natalia Andryszak, Daria Świniuch, Elżbieta Wójcik, Rodryg Ramlau, Marek Ruchała and Rafał Czepczyński
Cancers 2024, 16(3), 667; https://doi.org/10.3390/cancers16030667
Available online: https://www.mdpi.com/2072-6694/16/3/667

5. “De-Escalation Surgery in cT3-4 Breast Cancer Patients after Neoadjuvant Therapy: Predictors of Breast Conservation and Comparison of Long-Term Oncological Outcomes with Mastectomy”
by Corrado Tinterri, Erika Barbieri, Andrea Sagona, Alberto Bottini, Giuseppe Canavese and Damiano Gentile
Cancers 2024, 16(6), 1169; https://doi.org/10.3390/cancers16061169
Available online: https://www.mdpi.com/2072-6694/16/6/1169

6. “High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer”
by Minna M. Jääskeläinen, Ritva Tumelius, Kirsi Hämäläinen, Kirsi Rilla, Sanna Oikari, Aino Rönkä, Tuomas Selander, Arto Mannermaa, Satu Tiainen and Päivi Auvinen
Cancers 2024, 16(3), 634; https://doi.org/10.3390/cancers16030634
Available online: https://www.mdpi.com/2072-6694/16/3/634

7. “Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets”
by Amalia Sofianidi, Ecaterina E. Dumbrava, Konstantinos N. Syrigos and Azadeh Nasrazadani
Cancers 2024, 16(6), 1139; https://doi.org/10.3390/cancers16061139
Available online: https://www.mdpi.com/2072-6694/16/6/1139

8. “Systemic and Local Strategies for Primary Prevention of Breast Cancer”
by Erin K. Zaluzec and Lorenzo F. Sempere
Cancers 2024, 16(2), 248; https://doi.org/10.3390/cancers16020248
Available online: https://www.mdpi.com/2072-6694/16/2/248

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office